Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as $34.00 and last traded at $34.35, with a volume of 281449 shares trading hands. The stock had previously closed at $35.06.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on SLP shares. StockNews.com raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. William Blair restated an "outperform" rating on shares of Simulations Plus in a research report on Wednesday, January 8th. Finally, KeyCorp upped their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 16th. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $50.00.
View Our Latest Stock Analysis on SLP
Simulations Plus Trading Down 0.7 %
The company has a market capitalization of $670.10 million, a price-to-earnings ratio of 83.30 and a beta of 1.13. The business's 50 day moving average price is $28.64 and its two-hundred day moving average price is $30.36.
Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. During the same quarter in the previous year, the firm posted $0.20 earnings per share. The company's revenue was up 22.5% on a year-over-year basis. Analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current year.
Insider Activity
In related news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the sale, the director now owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. The trade was a 0.59 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 19.40% of the company's stock.
Hedge Funds Weigh In On Simulations Plus
A number of hedge funds have recently made changes to their positions in the stock. Barclays PLC boosted its position in Simulations Plus by 390.6% during the third quarter. Barclays PLC now owns 28,473 shares of the technology company's stock valued at $911,000 after acquiring an additional 22,669 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of Simulations Plus by 2.6% during the 3rd quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company's stock worth $2,794,000 after purchasing an additional 2,226 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Simulations Plus by 106.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock valued at $1,517,000 after buying an additional 24,371 shares during the period. Tributary Capital Management LLC increased its position in Simulations Plus by 21.7% in the 4th quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company's stock valued at $11,047,000 after buying an additional 70,526 shares in the last quarter. Finally, Cook Wealth LLC raised its stake in Simulations Plus by 19.1% during the 4th quarter. Cook Wealth LLC now owns 12,386 shares of the technology company's stock worth $345,000 after buying an additional 1,984 shares during the period. 78.08% of the stock is currently owned by institutional investors.
Simulations Plus Company Profile
(
Get Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Further Reading
Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
